Sertraline Hydrochloride
- Product NDC
- 43353-970
- 11-digit product format
- 433530970
- Labeler code
- 43353
- Product ID
- 43353-970_1e0a30cf-a624-4b41-aa91-c6fde1419cdf
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Sertraline Hydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- ANDA077397
- Marketing category
- ANDA
- Marketing start
- 2007-10-18
- Marketing end
- 0000-00-00
- Substance
- SERTRALINE HYDROCHLORIDE
- Active strength
- 25 mg/1
- Pharmacologic classes
- Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 43353-970 | SERTRALINE HYDROCHLORIDE TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 1 | Legacy NDC | 20160707_37d03cf5-3011-40fe-87f7-4205ba6dd1bb.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 43353-970-30 | 43353097030 | 30 TABLET in 1 BOTTLE (43353-970-30) | 30 tablet | 2014-10-09 | 0000-00-00 | No | No | Current |